Home » Reports » GlaxoSmithKline plc 28.1% Potential Upside Indicated by DZ Bank

GlaxoSmithKline plc 28.1% Potential Upside Indicated by DZ Bank

GlaxoSmithKline plc with EPIC/TICKER (LON:GSK) had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘BUY’ today by analysts at DZ Bank. GlaxoSmithKline plc are listed in the Health Care sector within UK Main Market. DZ Bank have set their target price at 1900 GBX on its stock. This would indicate that the analyst believes there is a potential upside of 28.1% from the opening price of 1483 GBX. Over the last 30 and 90 trading days the company share price has decreased 147 points and decreased 297.2 points respectively. The 52 week high share price is 1857 GBX while the year low share price is currently 1328.19 GBX.

GlaxoSmithKline plc has a 50 day moving average of 1,648.16 GBX and a 200 day moving average of 1,701.71. There are currently 5,017,018,827 shares in issue with the average daily volume traded being 17,029,167. Market capitalisation for LON:GSK is £74,059,649,407 GBP.

Join us on our new LinkedIn page

Follow us on LinkedIn